Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs
role Nice has played since its creation in 1999 as the arbiter of which medicines constitute value for money for the [NHS](https://www.theguardian.com/society/nhs) to buy – and thus which patients can receive – in England